According to Mainz Biomed's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.24. At the end of 2024 the company had a P/S ratio of 11.2.
Year | P/S ratio | Change |
---|---|---|
2024 | 11.2 | -57.5% |
2023 | 26.4 | -86.41% |
2022 | 194 | -7.91% |
2021 | 211 |